As a busy PI conducting research, have you ever wondered why your institution asks you to complete certain agreements related to your research and what do they all mean. In a recent article in Nature Biotechnology, Dr. Colm Lawler, Senior Licensing Manager, from Partners Innovation and his co-authors from NYU…

Click here to watch the full length video. Much of the research conducted at our hospitals is applied to finding new treatments for some of the world’s most intractable diseases.  Collaborating with an industry partner on this research can be essential to keeping the research focused on a commercially viable…

Both genetic and lifestyle factors are key drivers of coronary artery disease, a complex disorder that is the leading cause of death worldwide. Long recognized to be heritable, genomewide association analyses have identified more than 50 independent variants robustly associated with risk of coronary disease. These risk alleles, when aggregated…

Ribonucleic acid, or RNA, is one of the three major biological macromolecules that are, along with DNA and proteins, essential for all known forms of life. Recently, types of RNA called microRNAs (miRNA) and long-non-coding RNAs (lncRNAs) have been found to play important roles in gene regulation, capturing international scientific…

Exercise prescription upon completion of cancer therapies could improve fitness, as well as cardiovascular and cancer outcomes for select cancer survivors. Given the growing population of cancer survivors, exercise prescription has tremendous clinical and commercial potential. Advances in cancer care have achieved significant improvements in cancer survival, such that the…

In the last decade, there has been a revolution in transcatheter therapies for structural heart disease. The most widely embraced, transcatheter aortic valve replacement (TAVR), was originally intended for patients with aortic stenosis, in whom surgery was considered prohibitive, but it has now been utilized as an excellent alternative to…

The opportunities and challenges of commercializing Healthcare Information Technology, or HIT, are different from those in licensing other patent-protected technologies. The third Symposium Series session, held on December 7th, took up that challenge and focused on the many activities Partners is engaged in to facilitate development of cutting edge HIT…

Embryonic stem cells and induced pluripotent stem cells, which can be propagated indefinitely in culture in an undifferentiated state or induced to differentiate into every cell type in the adult body, holds promise for regenerative medicine. Proper execution of these distinct but developmentally relevant programs requires precise tuning of gene…

More than 17 million deaths worldwide were attributed to heart disease in 2016, and cardiovascular ailments persistently remain one of the biggest causes of hospital admissions in the United States. Cardiovascular disease also accounts for more healthcare costs than any other chronic illness, and is responsible for one out of…

The 2018 World Medical Innovation Forum focuses on the advancements and opportunities of AI in healthcare. This document aims to provide participants with a common framing of AI in healthcare. To download a PDF of the white paper, click here. Defining Artificial Intelligence If intelligence is understood to mean traits…